Real-World Data Collection for High-Risk Implantable Medical Devices Now Allowed in South Korea
The amended Enforcement Decree of the Medical Device Act took effect upon promulgation on July 22, 2025. Provisions related to processing personal information will come into force on August 1, 2025.
The
amendment provides a legal basis for Korea’s Minister of Food and Drug Safety
(MFDS) and local governments to process sensitive and personally identifiable
information when necessary to collect, analyze, and evaluate real-world data
generated during the use of certain medical devices. This change follows a
revision to the Medical Device Act that enables the designation of devices
requiring long-term follow-up due to frequent or serious adverse effects after
insertion into the human body.
Personal
information may also be processed when responding to adverse events, including
reporting, recall, and notification involving patients who have used the
relevant devices.
For any inquiries regarding medical device certification in South Korea, don’t hesitate to reach out to GCA KOREA. Our specialists are ready to offer timely and precise support throughout the certification and approval process.
Comments
Post a Comment